CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Long-term real-world entecavir therapy in treatment-naïve hepatitis B patients: base-line hepatitis B virus DNA and hepatitis B surface antigen levels predict virologic response
Ju-Yeon Cho, Won Sohn, Dong-Hyun Sinn, Geum-Youn Gwak, Yong-Han Paik, Moon Seok Choi, Kwang Cheol Koh, Seung Woon Paik, Byung Chul Yoo, Joon Hyeok Lee
Korean J Intern Med. 2017;32(4):636-646.   Published online 2016 November 4    DOI: https://doi.org/10.3904/kjim.2016.096

Excel Download

Long-term real-world entecavir therapy in treatment-naïve hepatitis B patients: base-line hepatitis B virus DNA and hepatitis B surface antigen levels predict virologic response
The Korean Journal of Internal Medicine. 2017;32(4):636-646   Crossref logo
Link1 Link2 Link3

Comparison between quantitative hepatitis B surface antigen, hepatitis B e-antigen and hepatitis B virus DNA levels for predicting virological response to pegylated interferon-α-2b therapy in hepatitis B e-antigen-positive chronic hepatitis B
Hepatology Research. 2010;40(3):269-277   Crossref logo
Link1

Long-term entecavir or tenofovir disoproxil fumarate therapy in treatment-naïve chronic hepatitis B patients in the real-world setting
Journal of Viral Hepatitis. 2014;22(5):504-510   Crossref logo
Link1

Long-term entecavir therapy results in falls in serum hepatitis B surface antigen levels and seroclearance in nucleos(t)ide-naïve chronic hepatitis B patients
Journal of Viral Hepatitis. 2013;21(11):802-808   Crossref logo
Link1

Pretreatment HBeAg level and an early decrease in HBeAg level predict virologic response to entecavir treatment for HBeAg-positive chronic hepatitis B
Journal of Viral Hepatitis. 2011;19(2):e41-e47   Crossref logo
Link1

Week 4 viral load predicts long-term suppression of hepatitis B virus DNA during antiviral therapy: improving hepatitis B treatment in the real world
Internal Medicine Journal. 2017;47(1):50-56   Crossref logo
Link1 Link2 Link3

469 Decline in Hepatitis B Surface Antigen Levels With Entecavir Treatment in HBeAg-Positive Nucleoside Naive Chronic Hepatitis B Patients-Results From Phase III Study ETV-022
Gastroenterology. 2012;142(5):S-917   Crossref logo
Link1 Link2

Effects of Entecavir on Hepatitis B Virus Covalently Closed Circular DNA in Hepatitis B e Antigen-Positive Patients with Hepatitis B
PLOS ONE. 2015;10(2):e0117741   Crossref logo
Link1

Efficacy of lamivudine in patients with hepatitis B e antigen-negative/hepatitis B virus DNA-positive (precore mutant) chronic hepatitis befficacy of lamivudine in patients with hepatitis B e antigen-negative/hepatitis B virus DNA-positive (precore mutant) chronic hepatitis befficacy of lamivudine in patients with hepatitis B e antigen-negative/hepatitis B virus DNA-positive (precore mutant) chronic hepatitis befficacy of lamivudine in patients with hepatitis B e antigen-negative/hepatitis B virus DNA-positive (precore mutant) chronic hepatitis BB
Hepatology. 1999;29(3):889-896   Crossref logo
Link1

P112: Hepatitis C virus NS3 polymorphism Q80K in genotype 1 therapy-naive Brazilian patients
Journal of Viral Hepatitis. 2015;22:77-77   Crossref logo
Link1

This metadata service is kindly provided by CrossRef from May 29, 2014. Korean J Intern Med has participated in CrossRef Text and Data Mining service since August 31, 2015.